Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease: Markers, Mediators, and Regulators?CAPLIN, Ben; LEIPER, James.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 6, pp 1343-1353, issn 1079-5642, 11 p.Article

Patients' perspective of haemodialysis-associated symptomsCAPLIN, Ben; KUMAR, Sanjeev; DAVENPORT, Andrew et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 8, pp 2656-2663, issn 0931-0509, 8 p.Article

Circulating methylarginine levels and the decline in renal function in patients with chronic kidney disease are modulated by DDAH1 polymorphismsCAPLIN, Ben; NITSCH, Dorothea; NORMAN, Jill et al.Kidney international. 2010, Vol 77, Num 5, pp 459-467, issn 0085-2538, 9 p.Article

Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood PressureCAPLIN, Ben; ZHEN WANG; SLAVIERO, Anna et al.Arteriosclerosis, thrombosis, and vascular biology. 2012, Vol 32, Num 12, pp 2892-2900, issn 1079-5642, 9 p.Article

Prospective Monitoring of Epstein-Barr Virus DNA in Adult Renal Transplant Recipients During the Early Posttransplant Period : Role of Mycophenolate MofetilHOLMES, Michael V; CAPLIN, Ben; ATKINSON, Claire et al.Transplantation. 2009, Vol 87, Num 6, pp 852-856, issn 0041-1337, 5 p.Article